FDA approves Valeant's one-week antifungal cream

11/17/2013 | Drug Store News

The FDA approved Valeant Pharmaceuticals' Luzu (luliconazole) antifungal cream in the 1% strength to address athlete's foot, jock itch and ringworm in adults. The medication "is the first safe and effective product indicated for daily use over a one-week period," said Valeant Chairman and CEO J. Michael Pearson.

View Full Article in:

Drug Store News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX